Apr 8, 2018 | Featured, Research News, Technology Updates
Eli Lilly ponies up $63M for Sigilon’s diabetes cell therapies, according to Amirah Al Adrus of FierceBiotech.com, 4 April 2018. Eli Lilly is continuing its push into new diabetes products, paying $63 million up front to get its hands on Sigilon Therapeutics’...
Mar 29, 2018 | Featured, Technology Updates
Dexcom G6 cleared by FDA with no fingerstick calibrations 10-day wear time approval for ages 2 years and older no acetaminophen interference and more The FDA just cleared the Dexcom G6 CGM today, only six months after it was submitted to the FDA and far earlier...